Logistic regression analyses validated the high efficacy of a combination of three biomarkers (APOE, APOAI, S100A8) in distinguishing TBM from non-TBM cases, with an AUC of 0.916, a sensitivity of 0.95, and a specificity of 0.775. This evidence concerns the gene APOA1 and meningeal tuberculosis.